Press Releases
-
AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations
Apr 28, 2026
-
Axithra Appoints Lars Kongsbak as CEO to Lead Next Phase of Growth and Series A Financing
Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer.
Apr 23, 2026
-
iProcess Global Research launches AxisOne: the R&D operating system for the world
iProcess Global Research Inc. today announced the launch of AxisOne, an AI-powered platform the company calls the R&D operating system for the world.
Apr 19, 2026
-
Leinco Technologies and CellCarta Collaborate to Advance Proteomics Solutions and Applications for Drug Development
Leinco Technologies and CellCarta are pleased to announce a strategic collaboration aimed at advancing proteomics solutions that will benefit the development of immuno-oncology and other targeted therapeutic modalities.
Apr 19, 2026
-
Takara Bio and Resistomap Deepen Collaboration to Advance One Health AMR Surveillance with the SmartChip Biosecurity Platform.
Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput antimicrobial resistance surveillance from environmental samples.
Apr 16, 2026
-
Aragen Launches ‘ChemiSHE’, India’s First Women-Led Chemistry Synthesis Laboratory
Apr 14, 2026
-
Ardena opens new bioanalytical laboratory in Somerset, New Jersey
Apr 14, 2026
-
Medix Biochemica appoints Petra Furu as Chief Executive Officer
The Board of Directors of Medix Biochemica appoints Petra Furu as Chief Executive Officer of the company, effective 1 June 2026.
Apr 14, 2026
-
Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays
Biognosys Group today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research to advance the development of highly sensitive and quantitative biomarker assays for Parkinson’s disease.
Apr 13, 2026
-
Enhanced Compliance Inc. (ECI) Appoints Khalid Raja as Senior Vice President, Strategic Growth & Advisory
Enhanced Compliance Inc. today announced the appointment of Khalid Raja (Raj) as Senior Vice President, Strategic Growth & Advisory, effective April 13, 2026.
Apr 13, 2026
-
START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research
Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas.
Apr 8, 2026
-
New Peer-Reviewed Scientific Publication Establishes Rationale for Combination Pharmacotherapy in Achieving Durable Weight Management
Review highlights multi-pathway, mechanistically informed approaches to obesity treatment
Apr 9, 2026
-
Ofichem unifies brands under single CDMO and pharmaceutical supplier
Apr 9, 2026
-
Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy
Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy
Apr 7, 2026
-
Plasmidsaurus Accelerates RNA-Seq: New EU Hub and Genovis Partnership Adds Stability to Speed, Without the Ice
Plasmidsaurus has announced two transformative evolutions of its RNA-Seq ecosystem.
Apr 1, 2026
-
Symbiosis Expands Commercial Capabilities with Addition of New Stability Chamber
Mar 31, 2026
-
LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture
LabConnect has launched SampleGISTICS 2.0, a mobile application designed to replace legacy digital pen technology and paper-based requisitions with a smartphone-based workflow. The platform enables clinical research sites to scan and transmit sample data in real time, providing immediate visibility into sample location and stability from the point of collection through laboratory intake. This digitization aims to reduce manual data entry errors and streamline logistics for global decentralized clinical trials.
Mar 30, 2026
-
Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer
Mar 30, 2026
-
Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimization
Lonza has announced the launch of its Media Development Lab at its Singapore site.
Mar 25, 2026
-
Multi-Arm PEG Architectures Expand Options for Long-Acting Biologic Development
Biopharma PEG highlights high-purity multi-arm PEG reagents designed to support PEGylation research and therapeutic conjugation development
Mar 23, 2026






